Related Experiment Video
Updated: Jun 14, 2026
14:39
Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022
Polyphenols and aging.
Brannon L Queen1, Trygve O Tollefsbol
1Department of Biology, University of Alabama at Birmingham, AL 35294, USA.
Current Aging Science
|March 20, 2010
Summary
Polyphenols show promise in combating age-associated diseases like Alzheimer's and cancer. These compounds may protect cells from damage, inhibit tumor growth, and reduce inflammation, suggesting potential as future therapies.
Area of Science:
- Nutritional science
- Gerontology
- Molecular biology
Background:
- Aging involves complex, multi-level functional declines affecting tissues.
- Age-associated diseases like Alzheimer's disease (AD) and cancer are linked to tissue dysfunction.
- Dietary polyphenols are increasingly recognized for their protective effects against age-related disorders.
Purpose of the Study:
- To review the protective mechanisms of polyphenols against age-associated cellular damage and diseases.
- To explore the role of polyphenols as potential anticancer and anti-inflammatory agents.
- To assess the therapeutic potential of polyphenols for age-associated human diseases.
Main Methods:
- Review of existing scientific literature on polyphenol mechanisms.
- Analysis of studies on polyphenols (e.g., resveratrol, EGCG, curcumin) and their effects on cellular damage.
- Examination of research on polyphenol's impact on angiogenesis, cell signaling (SIRT1), and vascular inflammation.
Main Results:
- Polyphenols can mitigate cellular damage from reactive oxygen species (ROS).
- Evidence suggests polyphenols act as anticancer agents by inhibiting neovascularization and influencing cell signaling.
- Polyphenols demonstrate anti-inflammatory effects relevant to atherosclerosis.
Conclusions:
- Polyphenols possess diverse mechanisms to combat age-associated cellular damage and disease.
- Further research into polyphenols may lead to novel pharmacological interventions for age-related conditions.
- Polyphenols show potential for therapeutic development against specific age-associated diseases.
Related Concept Videos
01:17Oxidation of Phenols to Quinones
In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox property is crucial in...
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox property is crucial in...
01:26Aging
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:19The Effect of Aging on Tissues
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...